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Epidermolysis bullosa (EB) is a rare and genetically heterogeneous disorder characterized
by skin fragility and blister formation occurring spontaneously or after minor trauma. EB is
accompanied by congenital absence of skin (EB with CAS) in some patients. Pathogenic
variants of COL7A1 are responsible for EB with CAS in the vast majority of cases. Type and
subtype diagnosis of EB with CAS generally requires speciﬁc immunohistological
examinations that are not widely available plus targeted gene analysis. The present
study aimed to determine the clinical features of ﬁve patients affected by EB with CAS
and to identify the underlying genetic defects using whole exome sequencing (WES)
followed by focused analysis of the target genes. Four patients had generalized skin
involvement and one had localized defects. Two patients exhibited extremely severe skin
manifestations and congenital cloudy cornea along with pyloric atresia, and one had partial
esophagogastric obstruction and anuria due to vesicoureteric obstruction. In the WES
analysis, the average coverage of the target exons was 99.05% (726 of 733 exons), with a
range of 96.4–100% for individual genes. We identiﬁed four novel and two known
pathogenic/likely pathogenic variants of ﬁve distinct genes in the examined families: PLEC:
c.2536G > T (p.Glu846Ter); LAMC2:c.3385C > T (p.Arg1129Ter); KRT5:c.429G > A
(p.Glu477Lys); ITGB4:c.794dupC (p.Ala266SerfsTer5); COL7A1:c.5440C > T
(p.Arg1814Cys); and COL7A1:c.6103delG. All alleles were inherited from the parents,
except for the KRT5 variant as a de novo ﬁnding. The ﬁndings reveal extremely rare
phenotypes found in EB with CAS, namely congenital cloudy cornea, esophagogastric
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obstruction, and anuria, and extend the genotypic spectrum of EB-related genes. The data
conﬁrm that WES provides very high coverage of coding exons/genes and support its use as a
reasonable alternative method for diagnosis of EB. The present data from an
underrepresented population in Southeast Asia could further broaden the knowledge and
research on EB.
Keywords: bilateral hydronephrosis, cloudy cornea, epidermolysis bullosa with pyloric atresia, intestinal
obstruction, reﬂux nephropathy

INTRODUCTION

METHODS

Epidermolysis bullosa (EB) is an inherited mechanobullous
disorder characterized by skin fragility and blister formation
occurring spontaneously or after minor trauma. It is classiﬁed
into four main types based on the level of separation of the skin:
EB simplex (EBS), junctional EB (JEB), dystrophic EB (DEB), and
Kindler EB (KEB) (Has et al., 2020a). EB is known to exhibit high
genetic heterogeneity.
EBS is the most common form of EB and is characterized by
blister formation within the epidermis arising from cleavage
within the basal layer. Most cases of EBS are caused by
dominant mutations of KRT5 (keratin 5), KRT14 (keratin
14), and KLHL24, with a few cases linked to recessive variants
of PLEC, KRT5, KRT14, and other genes (Fine et al., 2014; Has
et al., 2020b; Mariath et al., 2020). JEB involves separation
between the dermis and the epidermis (lamina lucida) and is
mostly inherited in an autosomal recessive mode. DEB is
characterized by separation within the uppermost dermis
(sublamina densa) and has two subtypes, autosomal
dominant DEB (DDEB) and autosomal recessive DEB
(RDEB), that both arise from mutations in COL7A1
(collagen type VII). KEB affects mixed layers of the skin
and is associated with photosensitivity (Has et al., 2020a).
EB with congenital absence of skin (CAS), previously named Bart
syndrome, is considered a clinical ﬁnding under the umbrella of EB
(Fine et al., 2014; Has et al., 2020b). EB with CAS can be diagnosed
based on clinical ﬁndings. However, identiﬁcation of the layer of skin
cleavage and precise classiﬁcation of the EB type/subtype require
immunoﬂuorescence mapping and/or transmission electron
microscopy, preferably on newly-induced blisters (Has et al., 2020a).
The most common EB type associated with CAS is DEB
(58–64%) arising from COL7A1 mutations, followed by JEB
(linked to ITGB4) and EBS in that order (Mariath et al., 2020;
Martinez-Moreno et al., 2020). Recessive variants of LAMC2
(laminin-332), ITGA6 and PLEC are less frequently found in
these cases (Mariath et al., 2020; Martinez-Moreno et al.,
2020). Autosomal dominant EB with CAS is mainly caused
by monoallelic variants of KRT5 and KLH24. EBS-severe with
pyloric atresia (EBS-PA) is linked to mutations in PLEC, while
JEB-PA is caused by mutations in ITGB4 and rarely ITGA6
(Pfendner and Uitto, 2005; Natsuga et al., 2010a; Natsuga,
2015; Mariath et al., 2020).
Herein, we describe EB with CAS in ﬁve unrelated patients,
revealing rare phenotypes of congenital cloudy cornea,
esophagogastric obstruction, and anuria and the underlying
genetic defects.

Patients

Frontiers in Genetics | www.frontiersin.org

We encountered ﬁve patients with a clinical diagnosis of EB with
CAS during 2014–2020. Clinical and laboratory data were
collected from their medical records. All of the patients and
their parents were of Thai descent.
Peripheral blood samples from the index cases and their
parents were obtained for genetic analysis, after written
informed consent was received. The research protocol was
approved by the Ramathibodi Hospital Human Research
Ethics Committee (approval number: MURA 2020/837).
Individual written consent for photograph and publication was
obtained.

Whole Exome Sequencing and Data
Analysis
DNA was extracted from the peripheral blood samples using a
Gentra Puregene kit (QIAGEN , Hilden, Germany). WES was
performed on an IIumina HiSeq4000 or NovaSeq platform by
Macrogen (Seoul, Republic of Korea) using Agilent SureSelect
(V5+UTR) for target captures (~22,000 genes; 100-bp pair-end
mode and 125x coverage of target regions). Analysis of the raw
genome sequencing data was as described in the Supplementary
material and previous established methods (Van der Auwera et al.,
2013).
Twenty-six genes known to be associated with EB were
analyzed: ATP2C1, CDSN, COL17A1, COL7A1, CSTA, DSG1,
DSG2, DSG4, DSP, DST, EXPH5, FERMT1, GRIP1, ITGA3,
ITGA6, ITGB4, KLHL24, KRT1, KRT5, KRT14, LAMA3,
LAMB3, LAMC2, PKP1, PLEC, and TGM5. These genes were
chosen following one of the widely available commercial panels
for epidermolysis bullosa (Blueprint Genetics , https://
blueprintgenetics.com).
Variants with minor allele frequency (MAF) > 0.05 were
ﬁltered out, in accordance with the population database
(http://gnomad.broadinstitute.org/) and 2015 guidelines of the
American College of Medical Genetics and Genomics and the
Association of Molecular Pathology (ACMG/AMP) (Richards
et al., 2015). Subsequently, the frequencies of the identiﬁed
variants were checked against the Thai Reference Exome
Database (T-REx, https://trex.nbt.or.th/).
The pathogenicities of the identiﬁed variants were determined
using previous reports and disease databases including ClinVar
(https://www.ncbi.nlm.nih.gov/clinvar/), the Human Gene
Mutation Database (HGMD), and the ACMG/AMP guidelines
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TABLE 1 | Patients’ clinical characteristics including outcomes and responsible genetic defects.
Characteristics
Gestational age (wk)
Birth weight (g)
Sex
Parental
consanguinity
Skin/oral ﬁndings
Aplasia cutis:
distribution

Patient 1

Patient 2

Patient 3

Patient 4

Patient 5

34
2,000
Female
Yes

35
1,800
Male
No

33
1,627
Male
No

31
1,650
Male
No

39
3,335
Male
No

Generalized: extensive
over face, neck, chest,
UE, LE
DOL1 (few hr)

Generalized: extensive over
UE, LE

Generalized: extensive over
abdomen, UE, LE

Localized: right
ankle

DOL4

DOL1

Generalized: extensive: over
scalp, face, neck, UE, LE,
perineum
DOL2 (36 h)

No?
No

Yes
Abdominal wall, upper
thighs, feet, later over the
entire body
Yes
No
Yes

No
Periumbilical, areas attached with
adhesive

Yes
Extremities

NA
NA
NA

Yes
Hands, elbow, buttocks,
post-auricular; later over the
entire body
NA
No
Yes

NA
Yes
NA

No
No
No

Eye

Congenital cloudy cornea

No

No

No

Gastrointestinal

Pyloric atresia

Difﬁculty sucking

Difﬁculty sucking

Urogenital

No

No

No

Musculoskeletal
Outcomes: age,
clinical course

Ankle contracture
Dead: DOL1, breathing
stopped

Ankle contracture
Dead: DOL35, sepsis
(catheter-related)

No
Dead: DOL44, sepsis,
palliative care

Congenital cloudy cornea,
absent eyelashes
Partial esophagogastric
obstruction, pyloric atresia
Urethral meatal stricture,
vesicoureteral stricture,
hydroureter, anuria
No
Dead: DOL2, acute kidney injury,
anuria

Genetic defects

PLEC

LAMC2

KRT5

ITGB4

Blister formation:
Onset
Oral blister
Other areas

Atrophic scar
Dystrophic nails
Reticulated
erythema

DOL 1

Extracutaneous
features

No
No

No
Alive:11 mo,
discharged on
DOL10
COL7A1

DOL, day of life; hr, hours; LE, lower extremities; mo, months; NA, not available; UE, upper extremities; wk, weeks.

diagnosis because a speciﬁc immunohistopathological diagnostic
facility was unavailable. The characteristics of the ﬁve patients
and pedigrees and their skin lesions are described below and/or
shown in Table 1 and Figures 1, 2, and the Supplementary
Figure S1.

(Richards et al., 2015). The searches were performed using a
variant prediction software, VarSome, (https://varsome.com/),
that incorporates a set of 14 computational prediction
programs (REVEL, DANN, DEOGEN2, FATHMM-MKL,
LIST-S2, M-CAP, MVP, PolyPhen2, MutationTaster,
BayesDel_addAF, EIGEN, MutationAssessor, PrimateAI and
SIFT) for prediction of pathogenicity.
Sanger sequencing was carried out to conﬁrm the alleles
identiﬁed by WES in the patients and their family members.
Segregation analysis was performed to determine the inheritance
pattern. Primers with intronic ﬂanking sequence were designed
using PRIMER3 software (http://frodo.wi.mit.edu). Lists of the
primer sequences and GenBank reference sequences are provided
in the Supplementary Table S1.

Patient 1
Patient 1 was a 34-weeks gestational age (GA) female neonate born to
a G4P3 woman. Her birth weight was 2,000 g and she had Apgar
scores of 9 and 10 at 1 and 5 min, respectively. Physical examination
revealed hypotonia and extensive CAS with well-demarcated
erythematous atrophic patches on her neck, trunk, and upper and
lower extremities, including the hands, legs and feet. There was large
erosion at the central part of the face, infraorbital area, and nose.
Cloudy cornea was noted. A babygram was suggestive of pyloric
atresia. The patient developed multiple bullae at different sites of the
entire body, and died a few hours after birth. The parents were third
cousins and were 42 years of age. Their ﬁrst and third children were
healthy, while the second child was affected by extensive skin defects
at birth and died on the ﬁrst day of life (DOL), with no available
medical records or photographs for review.

RESULTS
Clinical Data
Five patients (4 males, one female) were enrolled in the study.
None of the patients had histological conﬁrmation of the EB type

Frontiers in Genetics | www.frontiersin.org
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FIGURE 1 | Characteristics of skin involvement and other abnormalities of Patients 1–3 and 5. (A) Patient 1: marked multiple absence of skin and well-demarcated
erythematous atrophic patches on the face, neck, upper chest wall, and upper and lower extremities; and x-ray showing single large gastric bubble suggesting pyloric
atresia. (B) Patient 2: well-demarcated erythematous atrophic patches and absence of skin on both legs, extending to the feet, and tense large bullae at the posterior
aspect of left ear pinna, sacral area, and buttocks. (C) Patient 3: notable well-deﬁned erythematous atrophic patches and absence of skin at the abdominal wall,
forearms, and both legs. (D) Patient 5: localized absence of skin at the dorsum of the right foot up to the ankle.

FIGURE 2 | Characteristics of skin involvement and other abnormalities of Patient 4. (A) Skin involvement: marked complete absence of skin over the
parietotemporal region of the scalp and extending downward to the interorbital and midfacial areas including the nasal region; perineal area; upper and lower extremities
including thighs, legs, feet, arms, forearms, and hands; bilateral cloudy cornea, ectropion of the left lower eyelid and dysplastic ears. (B) Pyloric atresia: an upper
gastrointestinal study showing a gastric outlet obstruction and abdominal ultrasound showing large air-ﬁlled stomach. (C) Abdominal ultrasound demonstrating
multi-leveled urinary tract obstructions: severe hydronephrosis of the left kidney (far left); left ureteropelvic junction obstruction (middle); and a small and collapsed urinary
bladder and markedly dilated left ureter, signifying a vesicoureteric junction obstruction (far right). Similar ﬁndings were observed on the right kidney and ureter (data not
shown).
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Patient 2

elevated serum creatinine level indicating acute kidney injury
were also noted. Abdominal ultrasonography revealed smallsized bladder, severe hydroureter and hydronephrosis,
suggesting obstruction at the vesicoureteric junction. There
were difﬁculty passing an orogastric tube gauge #6 farther
than 15 cm from the oral opening, raising suspicion of a
stricture at the esophagogastric junction. An orogastric tube
gauge #10 was successfully passed to the stomach. A plain
X-ray of the abdomen, ultrasonography, and upper
gastrointestinal study were performed and demonstrated a
pyloric stricture. On DOL2, the patient developed multiple
peeled-off skin areas and a few blisters, particularly around
the application sites of adhesive materials. The patient
expired on the same day. The was no parental consanguinity.

Patient 2 was a male infant, ﬁrst child of the family, born at
35 weeks GA with a birth weight of 1,800 g and Apgar scores
of 9 and 10 at 1 and 5 min, respectively. Physical
examination showed generalized well-demarcated absence
of skin over the dorsum of the hands, the anteromedial
aspect of the legs and the dorsum of the feet. Both ankles
were in a ﬁxed dorsiﬂexion position. No nail deformity was
noted. On DOL4, multiple bullae formed on his ﬁngers,
elbows, buttocks, and left postauricular area, and
subsequently developed over the whole body. General
supportive treatment and antibiotics were given.
However, at 1 month of age, the patient exhibited high
fever and had pus oozing from the umbilical venous
catheter insertion site, resulting in sepsis and death. The
parents were aged 17 and 23 years at the time of his birth
and had no known consanguinity despite originating from a
close district.

Patient 5
Patient 5 was a 39 weeks GA male infant who was vaginally
delivered by a G1P0 woman aged 24 years. The Apgar scores
were 9 and 10 at 1 and 5 min, respectively, and the birth
weight was 3,355 g. At birth, he was noted to have localized
CAS at the dorsum of the right foot up to the ankle, with two
large blebs on his upper and lower gums. The patient was
discharged to home on DOL7. The CAS lesion
gradually improved with complete healing by 3 weeks. Skin
blistering did not appear until 3 months of age, when he
developed small blebs on his right ankle and his gums,
requiring local skin care that led to healing without scars.
No milia formation or skin reticulation was observed. At the
time of this report, the patient is 10 months of age with
normal growth and development. His family history
indicates no parental consanguinity. His father was
28 years of age.

Patient 3
Patient 3 was a 33 weeks GA male neonate who was vaginally
delivered by a G1P0 woman aged 32 years. The pregnancy was
complicated by gestational diabetes and preterm labor pain
and membrane rupture with clear amniotic ﬂuid for 2 days
before delivery, necessitating intrapartum antibiotic
prophylaxis and antenatal steroid to promote fetal lung
maturity. The Apgar scores were eight and nine at 1 and
5 min, respectively, and the birth weight was 1,627 g. The
infant had multiple well-deﬁned erythematous atrophic
patches and absence of skin noted at the abdominal wall,
arms, and legs. At 12 h after birth, he developed multiple
thin bullae at the abdominal wall, upper thighs, and
pressured areas, with subsequent peeling off of the skin.
Subsequent development of intraoral blisters led to erosive
lesions and sucking difﬁculty, necessitating orogastric tube
feeding. Despite provision of extensive wound care,
progressive scaring and recurrent bacterial sepsis followed,
leading to the decision for palliative care which resulted in
subsequent death on DOL44. Both parents were 32 years of age
and were a nonconsanguineous couple.

Whole Exome Sequencing Data and PLEC,
LAMC2, KRT5, ITGB4 and COL7A1 Variants
Given the lack of available specimens for Patient 1, we used
blood samples from his parents for a family duo WES analysis
and two unaffected siblings for additional segregation
analysis. For Patients 2–5, blood samples from the patients
only underwent singleton WES to reduce costs.
The average coverage of the target exons by WES was 99.05%
(726 of 733 exons), with a range of 96.4–100% for individual
genes. The coverage and missing regions for the target genes are
provided in the supporting information Supplementary
Table S2.
We identiﬁed seven pathogenic/likely pathogenic variants
(Figure 3) and 18 unknown signiﬁcant and benign/likely benign
variants (Supplementary Table S3). Details of the diseaseresponsible candidate variants, including their inheritance
status, are shown in Table 2. The novel variants were
submitted to ClinVar and assigned reference numbers
(Table 2).
A heterozygous variant of PLEC, c.2536G > T, resulting in a
change from glutamic acid to stop codon (p.Glu956Ter) was
found in the parents of Patient 1 and was not present in his
unaffected siblings. Therefore, homozygous PLEC:c.2536G > T

Patient 4
Patient 4 was noted to have fetal bilateral hydronephrosis and
hydroureter, as demonstrated by routine prenatal ultrasound
at 29 weeks. This male neonate was born at 31 weeks GA by
cesarean section due to preterm labor pain and premature
membrane rupture. He had Apgar scores of 4 and 10 at 1 and
5 min, respectively, and his birth weight was 1,650 g. There
was widespread complete absence of skin over the
parietotemporal region of the scalp, interorbital and
midfacial area including the nasal region, perineal area,
and upper and lower extremities including the thighs, legs,
feet, arms, forearms, and hands. Bilateral cloudy cornea,
ectropion of the left lower eyelid, and dysplastic ears were
noted. There were dystrophic nails and loss of the nail plate
on the second and third ﬁngers of the left hands. Bilateral
palpable ﬂank masses, absent urethral meatus, anuria, and
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FIGURE 3 | Chromatogram conﬁrming the sequences of the mutations in PLEC, LAMC2, KRT5, ITGB4, and COL7A1 identiﬁed in the study.

TABLE 2 | Variants and genotypes identiﬁed in the present study.
Genetic
defects

Patient 1

Patient 2

Patient 3

Patient 4

Patient 5

PLEC

LAMC2

KRT5

ITGB4

COL7A1

c.2536G > T
(rs1554713693)
Same as allele 1
SCV001934588:
present study

c.3385C > T
(rs201307156)
Same as allele 1
SCV001983770:
present study

c.1429G > A
(rs59190510)
—
VCV000021174: Lalor
L, et al., 2018

c.794dupC
(rs757050033)
Same as allele 1
SCV001934589:
present study

c.5440C > T (rs778035441)

21
p.Glu846Ter

23
p.Arg1129Ter

7
p.Glu477Lys

8
p.Ala266SerfsTer5

Pathogenic (PVS1,
PM2, PP3, PP5)

Pathogenic (PVS1,
PM2, PP5, PP3)

Pathogenic (PM1, PM2,
PP2, PP3, PP5)

Pathogenic (PVS1,
PM2, PP3)

Both—het c.2536G
>T
Inheritance
AR
gnomAD: MAF
0
T-REx: MAF
0
Characteristics of gene
Total exon
33
Amino acid
4,574
Ref. gDNA
NC_000,008.10
Ref. mRNA
NM_000,445.5
Ref. protein
NP_000,436.2

Both—het c.3385C
>T
AR
0
0

Both—normal
sequence
AD, de novo
0
0

Both—het c.794dupC
AR
0
0

Likely pathogenic: c.5440C > T (PM1, PM2,
PP2, PP3, PP5) and Pathogenic: c.6103delG
(PVS1, PM2, PP3)
Father - het c.5440C > T; mother - het
c.6103delG
AR
0/0
0/0

23
1,193
NC_000,001.10
NM_005,562.3
NP_005,553.2

9
590
NC_000,012.11
NM_000,424.4
NP_000,415.2

40
1,822
NC_000,017.10
NM_000,213.5
NP_000,204.3

119
2,944
NC_000,003.12
NM_000,094.4
NP_000,085.1

Gene
Variant identiﬁed
Allele 1
Allele 2
ClinVar:
Reference
Exon
Mutant
protein
Variant
classiﬁcation
Parental study

c.6103delG
VCV001047935.2 (c.5440C > T): Dang N, et al.,
2007 and SCV001934590 (c.6103delG):
present study
63 (c.5440C > T); 73 (c.6103delG)
p.Arg1814Cys and p.Glu2035SerfsTer171

AD, autosomal dominant; AR, autosomal recessive; het, heterozygous; MAF, minor allele frequency; Ref., reference sequence; T-REx, Thai reference exome database.

was inferred as the patient’s genotype, based on segregation
analysis using the assumption of autosomal recessive
inheritance. This variant has not previously been reported.
A homozygous novel variant in LAMC2, c.3385C > T, leading
to a stop codon (p.Arg1129Ter) was found in Patient 2. Both

Frontiers in Genetics | www.frontiersin.org

parents were heterozygous for the allele, as was a younger
unaffected sibling who was born before prenatal testing for
familial variants became available.
A heterozygous missense variant of KRT5, c.429G > A or p.
Glu477Lys, known to cause EB with CAS was detected in Patient
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3. As both parents had the normal sequence, this variant was a de
novo occurrence in the patient.
We detected a novel homozygous single nucleotide insertion,
c.794dupC, in ITGB4 of Patient 4. The parents were heterozygous
for the allele.
A genetic compound between a paternally inherited allele,
c.5440C > T (p.Arg1814Cys), and a maternally inherited variant,
c.6103delG, of COL7A1 was detected in Patient 5. The c.6103delG
was a novel ﬁnding.

with greater prematurity. We have noted substantial numbers of
premature births among previously reported cases with available
data, especially for patients with extensive cutis aplasia and
erosion of the skin (Charlesworth et al., 2003; Natsuga et al.,
2010b; Chen et al., 2018; Han et al., 2019).
We have described, for the second time, the presence of
congenital corneal cloudiness as a primary abnormality of the
cornea in two EB patients: Patient 1 with a PLEC mutation and
Patient 4 with an ITGB4 mutation. The ﬁrst case of congenital
corneal haziness in EB was recently described in a neonate with
RDEB due to COL7A1 mutations (Sawka et al., 2021). Ocular
manifestations in EB usually represent late complications
following exposure keratitis and scarring of the eyelids. Our
Patient 1 did not show any eye lid abnormality or corneal
scarring, while our Patient 4 showed ectropion on one eye but
bilateral cloudy cornea, suggesting an underlying mechanism
other than physical/rubbing trauma of the cornea.
The skin, oral mucosa, and outer surface of the cornea are
stratiﬁed
squamous
epithelium
containing
type
I
hemidesmosomes composed of plectin, integrin α6β4, BP230,
and BP180 (collagen type XVII) that link laminin-332 in the
basement membrane and lamina densa. The skin-type keratin
pair is K5/K14, while the cornea-type keratin pair is K3/K12
(Figure 4) (Walko et al., 2015; McKay et al., 2020). Collagen types
VII and IV are also expressed in the epithelial basement
membrane (EpBM) of the cornea and skin dermis. Integrin
α6β4 was shown to mediate adhesion of basal cells to the
corneal EpBM as well as to collagen, laminin, and other
extracellular matrix proteins including ﬁbronectins and
vitronectin (McKay et al., 2020). Decreased integrin expression
led to reduced proliferation of corneal epithelial cells and
impaired adhesion to the underlying basement membrane,
resulting in ocular surface defects (McKay et al., 2020). A
report on the histopathological ﬁndings for the anterior cornea
in an adult patient with EBS described normal superﬁcial and
intermediate corneal epithelia but abnormal structures in the
basement membrane, namely ﬁbrocellular pannus deep to the
thickened EpBM and multilaminar basement membrane with
faulty adhesion complexes (Adamis et al., 1993). Taken together,
these data suggest that the congenital corneal cloudiness in EB
could arise through primary malformation of the corneal
epithelium.
The partial obstruction of the esophagogastic junction in our
Patient 4 represents another rare gastrointestinal anomaly in EB,
as it has been previously reported in a few cases.(Doi et al., 1986;
Cetinkursun et al., 1995; Maman et al., 1998). These
gastrointestinal anomalies might have been underdiagnosed
because of the early demise of the patients. The PA and
esophagogastic atresia could be a result of intraluminal mechanical
and/or chemical irritation, leading to mucosal destruction and
followed by cicatrization. We further demonstrated the very rare
occurrence of a vesicoureteric obstruction with anuria in our Patient 4
with an ITGB4 mutation (Dang et al., 2008).
PLEC encodes plectin protein, which directly interacts with
keratin K5/K14 intermediate ﬁlaments and also binds to integrin
α6β4 and other related proteins to form a multiprotein complex
that stabilize the adhesion of basal keratinocytes (epithelial cells)

DISCUSSION
We identiﬁed pathogenic/likely pathogenic variants in ﬁve
different genes as the causes of EB with CAS in ﬁve unrelated
Thai families, including four novel recessive alleles in PLEC,
LAMC2, ITGB4, and COL7A1, and a known dominant mutation
in KRT5.
A handful of EB cases have been reported in Southeast Asian
populations including Thai, Malaysian, Singaporean, and
Indonesian (Singalavanija et al., 1994; Wessagowit et al., 2007;
Tang et al., 2013; Bishnoi et al., 2021) with only two studies
providing molecular data limited to COL7A1.(Wessagowit et al.,
2007; Bishnoi et al., 2021). One likely reason for the small number
of reports on EB with its type/subtype diagnosis in Thailand, at
least, is the lack of availability of sophisticated
immunohistopathological analyses speciﬁc for the disorder.
According to the recent 2020 clinical practice guidelines for
laboratory diagnosis of EB in affected neonates, a skin pathologic
study is recommended as the ﬁrst diagnostic step with a genetic
analysis performed in parallel (Has et al., 2020b). With the
advance of next-generation sequencing (NGS) technology
and its rapidly decreasing price, extended genetic testing
has become affordable and easier to access for
conﬁrmation of disorders with high genetic heterogeneity,
such as EB. When applied to our local context, WES was
chosen as the ﬁrst test in the present study.
Several studies using NGS multigene panels for EB diagnosis
have reported diagnostic yields of 83–97%, with the variation
arising from the characteristics of the examined populations such
as ethnicity and presence of consanguinity, as well as the cohort
size (40–91 families) and the number (11–49 genes) and details of
the genes on the NGS panels (Vahidnezhad et al., 2017; Has et al.,
2018; Lucky et al., 2018; Mariath et al., 2019). A study using WES
had a 100% detection rate in a cohort of 57 families affected by EB
of various types (Yu et al., 2021). The present study yielded 100%
detection frequency and revealed genetic heterogeneity in the
results, despite the very small cohort. The data support the use of
WES as a reasonable alternative method for diagnosis of EB and
conﬁrm that it provides very high coverage of target exons/genes.
However, the major limitation of genetic testing alone is the lack
of histological conﬁrmation of EB, and thus further insights into
the dermatopathogenic mechanisms are crucial for deeper
research on this disease.
In the present study, four patients, except for the patient with
the mildest manifestations, were born prematurely. Furthermore,
greater severity of CAS and skin erosion appeared to be associated

Frontiers in Genetics | www.frontiersin.org

7

April 2022 | Volume 13 | Article 847150

Pongmee et al.

EB-CAS: extended genotypic spectrum

FIGURE 4 | Schematic diagram showing basal keratinocytes and type I hemidesmosomes in the skin and corneal epithelium. Keratin intermediate ﬁlaments form
within the basal layer. Plectin, a hemidesmosomal protein, directly binds to the intermediate ﬁlaments and integrin α6β4, the latter interacts with BP230 and BP180.
Laminin-332 binds to integrin α6β4 and the anchoring ﬁbrils composed of collagen type VII.

to the underlying basement membrane (Walko et al., 2015). The
p. Glu956Ter variant could lead to a severely truncated protein
that lack the entire rod domain and the carboxy-terminal globular
domain of normal plectin, the latter of which functions as a β4integrin binding segment and a binding site for keratin
intermediate ﬁlaments. Therefore, the mutant protein is likely
to be nonfunctional or even not produced through activation of
nonsense-mediated mRNA decay, resulting in a fatal phenotype
(Natsuga et al., 2010a).
Premature truncation (PTC) mutations in PLEC were shown
to be associated with early lethality in patients with EBS-PA with CAS
(Charlesworth et al., 2003; Nakamura et al., 2005; Pfendner and Uitto,
2005; Natsuga, 2015). Three affected siblings described by
Charlesworth et al. (Charlesworth et al., 2003) showed similar
patterns of extensive skin involvement in scalp/facial regions, PA,
hypotonia, and early demise due to a PTC mutation in PLEC
(c.2727del14 in exon 22 of NM 00445.5. The extreme phenotypes
in these siblings were similar to the ﬁndings in our Patient 1, who
harbored a pathogenic variant in the adjacent exon of PLEC (c.2536G >
T, last nucleotide in exon 21 (NM_00,445.5). Molecular and
histopathologic studies in the siblings demonstrated that the
c.2727del14 allele led to PTC and total absence of plectin protein in
the skin annexes (Charlesworth et al., 2003). The unusual severity of
our Patient 1 and the patients reported by Charlesworth et al.
(Charlesworth et al., 2003) could be due to the critical position of
the mutations that cause PTC within the plakin globular domain of
plectin.
LAMC2 encodes the laminin γ2 subunit, which forms a
heterotrimer with the laminin α3 and laminin β3 subunits to form
laminin-332 (Walko et al., 2015). The variant LAMC2:c.3385C > T
(p.Arg1129Ter) is predicted to lose the carboxy-terminal 64 amino
acids, including the distal segment of the coiled-coil domain. LAMC2
is the only laminin gene found to have mutations in EBS with CAS,
with just ﬁve pathogenic variants described in previous reports,
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(Schneider and Muehle, 2008; Hammersen et al., 2016; Mariath
et al., 2020), making LAMC2 the rarest gene underlying the disorder.
Kertin 5 assembles with keratin 14 to form heterodimeric
and tetrameric proteins as the principal components of the
intermediate ﬁlaments in basal keratinocytes that are crucial
for mechanical stability (Walko et al., 2015; Khani et al.,
2018). KRT5:c.429G > A (p.Glu477Lys) was described as the
most common mutation in patients affected by EBS-severe with
CAS, and was a de novo event in the majority of cases (Lalor et al.,
2019; Mariath et al., 2020). The mutation is located at the last
amino acid in the highly conserved end of the α-helical
termination peptides critical for intermediate ﬁlament
formation. In silico modelling showed that the variant led to a
conformational change and an altered charge on the surface of the
keratin K5/K14 heterodimers, disrupting the stability of the
dimerization and thus intermediate ﬁlament formation (Lalor
et al., 2019). The variant was associated with a high mortality rate
(Sathishkumar et al., 2016; Lalor et al., 2019).
The integrin β4 subunit (encoded by ITGB4) and integrin α6
subunit form a heterodimeric protein at the lamina lucida of the skin
and at the corneal epithelium. ITGB4:c.794dupC is expected to result
in substitution of alanine with serine at codon 266, followed by a short
frameshift before premature termination ﬁve residues later, designated
p. Ala266SerfsTer5. Thus, the mutant protein lacks more than 80% of
the carboxy-terminus, and is likely nonfunctional or not synthesized
due to mRNA decay. Mutations of ITGB4 have been detected
throughout the gene. A patient described by Dang et al. (Dang
et al., 2008) with c.3903dupC/p.Gly 273Asp (in exon 31/exon 8),
exhibited widespread CAS and skin erosion over the scalp/facial/ear
regions, severe vesicoureteric obstruction, and anuria, reminiscent of
our Patient 4 who also had a mutation of exon 8 encoding the
N-terminal extracellular domain of the integrin β4 subunit. These
ﬁndings indicate possible correlations between mutations in exon 8
and extremely severe phenotypes.
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COL7A1 encodes the α1 subunit of type VII collagen, a major
collagenous component of the lamina densa and upper dermis.
Type VII collagen forms anchoring ﬁbrils between stratiﬁed
squamous epithelia and stroma (Chung and Uitto, 2010).
Many COL7A1 variants have been described to cause DDEB
and RDEB, depending on the nature and position of the
mutations. Speciﬁcally, PTC mutations in both COL7A1 alleles
tend to cause the RDEB-severe subtype, while a missense
mutation in at least one allele tends to lead to phenotypic
variability: intermediate or severe subtypes. In the present
study, the genetic compound between a missense allele and a
PTC mutation, p. Arg1814Cys/p.Glu2035SerfsTer171, led to a
nonlethal form of RDEB-intermediate (self-improving). Most
COL7A1 variants related to EB with CAS are aggregated in the
triple-helix domain (Mariath et al., 2020) encoded by exons
31–109 (Christiano et al., 1994). The p. Arg1814Cys was
predicted to produce an additional disulﬁde bond and disturb
the secretion of collagen type VII and the stability of the triple
helix (Dang et al., 2007).
We did not validate the predicted deleterious effect of the
relevant variants by gene expression at neither RNA nor protein
level, representing limitation of the present study.
CAS is present in 23% of EB patients (Mariath et al., 2019).
Although the exact pathogenesis of CAS in EB remains to be
resolved (Chiaverini et al., 2014), an acceptable long-held
hypothesis is that CAS results from in utero friction/trauma to
the limbs (Kanzler et al., 1992). However, the occurrence of
similar pattern and severity of CAS within the same family
cannot be explained by this assumption. Our data support an
alternative hypothesis, recently proposed by several authors,
(Charlesworth et al., 2003; Dang et al., 2008; Chiaverini et al.,
2014; Lalor et al., 2019; Mariath et al., 2020), that the mutation
type and position are the major contributing factors leading to
CAS in all EB type/subtype, as evidenced by speciﬁc
mutations/regions of the genes found to be linked with
recurrent patterns of manifestations in different families,
and the same severity and patterns of phenotypes seen in
affected individuals within the same families.
Consanguinity as a founder effect is not uncommon in
upcountry areas of Thailand, as demonstrated by the presence
of homozygous variant in three families (Patients 1, 2 and 4) in
the present study. The identiﬁcation of speciﬁc mutations allows
not only subtype classiﬁcation and prognostication, but also
precise genetic counselling and reproductive choices.
In conclusion, the present study has revealed exceptionally
rare phenotypes in EB with CAS, namely congenital corneal
cloudiness, esophageal obstruction, and anuria, and extended
the genotypic spectrum of EB-related genes. Our data from an

underrepresented population in Southeast Asia can further
broaden the knowledge and research on EB.
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